← ACCENDRA HEALTH INC/VA/ ACH
Market Price
$0.95
Market Cap
$84.24M
P/E Ratio
N/A
Revenue (FY 2025)
↓-74.2% YoY
$2.76B
3-Yr CAGR: -34.8%
Net Income
↓-203.5% YoY
-$1.10B
Net Margin: -39.8%
Free Cash Flow
↓-805.9% YoY
-$447.24M
FCF Yield: -530.90%
EPS (Diluted)
↓-202.5% YoY
$-14.31
Basic: $-14.31
Return on Equity
Efficiency
N/A
ROA: -200.9%
⚡ N/A due to negative equity (share buybacks or other)
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (ACH)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $9,723.4M | — | $1,187.3M | $108.8M | — | $1.76 | — | $186.9M | $166.6M | — |
| FY 2017 | $9,318.3M | -4.2% | $1,171.9M | $72.8M | -33.1% | $1.20 | -31.8% | $56.8M | $22.2M | -86.7% |
| FY 2018 | $9,838.7M | +5.6% | $1,367.0M | $-437.0M | -700.3% | $-7.28 | -706.7% | $115.6M | $70.7M | +219.1% |
| FY 2019 | $9,210.9M | -6.4% | $1,128.5M | $-62.4M | +85.7% | $-1.03 | +85.9% | $166.1M | $123.7M | +74.9% |
| FY 2020 | $8,480.2M | -7.9% | $1,280.8M | $29.9M | +147.9% | $0.47 | +145.6% | $339.2M | $288.8M | +133.5% |
| FY 2021 | $9,785.3M | +15.4% | $1,513.2M | $221.6M | +641.8% | $2.94 | +525.5% | $124.2M | $83.2M | -71.2% |
| FY 2022 | $9,955.5M | +1.7% | $1,826.4M | $22.4M | -89.9% | $0.29 | -90.1% | $325.0M | $166.9M | +100.6% |
| FY 2023 | $10,334.0M | +3.8% | $2,125.2M | $-41.3M | -284.5% | $-0.54 | -286.2% | $740.7M | $549.8M | +229.4% |
| FY 2024 | $10,700.9M | +3.6% | $2,219.2M | $-362.7M | -778.2% | $-4.73 | -775.9% | $161.5M | $-49.4M | -109.0% |
| FY 2025 | $2,762.0M | -74.2% | $1,289.3M | $-1,100.6M | -203.5% | $-14.31 | -202.5% | $-256.3M | $-447.2M | -805.9% |
Valuation
Market Price
$0.95
Market Cap
$84.24M
Enterprise Value
$302.25M
P/E Ratio
N/A
P/B Ratio
N/A
FCF Yield
-530.90%
Dividend Yield
-1,511.25%
Shares Outstanding
Profitability & Margins
Gross Margin
46.68%
Operating Margin
0.99%
Net Margin
-39.85%
Return on Equity (ROE)
N/A (Negative Equity)
Return on Assets (ROA)
-200.89%
Asset Turnover
5.04x
Revenue 3-Yr CAGR
-34.78%
Financial Health & Liquidity
Current Ratio
0.58
Cash Ratio
0.30
Debt / Equity
-1.085
Debt / Assets
0.913
Cash & Equivalents
$281.99M
Total Debt
$500.00M
Book Value / Share
$-6.02
Cash Flow Efficiency
Operating Cash Flow
-$256.29M
Capital Expenditures (CapEx)
$190.96M
Free Cash Flow
-$447.24M
OCF / Revenue
-9.28%
FCF / Revenue
-16.19%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-14.31
EPS (Basic)
$-14.31
Dividends / Share
$-14.31
Book Value / Share
$-6.02
EPS YoY Growth
-202.54%
Balance Sheet (FY 2025)
Total Assets
$547.87M
Total Liabilities
$947.08M
Stockholders' Equity
-$460.98M
Current Assets
$547.87M
Current Liabilities
$947.08M